Back
CytomX Therapeutics, Inc. Stock Predictions
Still Time to Get In: RAD Intel at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
51
CTMX
CytomX Therapeutics, Inc.
Last Price:
$3.96
Seasonality Move:
11.81%
7 Day Trial
ALL ACCESS PASS
$
7
This AI Layer Just Raised Its Share Price
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiCytomX Therapeutics, Inc. Stock Forecast
-
Is CytomX Therapeutics, Inc. Stock Undervalued?The current CytomX Therapeutics, Inc. [CTMX] share price is $3.95. The Score for CTMX is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
-
CTMX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will CytomX Therapeutics, Inc. Stock Go Up Next Year?
Data Unavailable
CytomX Therapeutics, Inc. Stock Rating
Data Unavailable
CytomX Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
cytomx.com
52-Week Data
52-Week High:
4.62
52-Week Low:
0.40
Prediction Charts
Market Cap:
669.3M
Price in USD:
3.95
Volume:
929.8K
Beta:
1.50
Technical Analysis
SMA50:
3.65
SMA100:
2.90
SMA200:
2.17
52-Wk Change:
240.52%
Stock Predictions
-
Is CytomX Therapeutics, Inc. stock public?Yes, CytomX Therapeutics, Inc. is a publicly traded company.
-
What is the CytomX Therapeutics, Inc. stock quote today?The CytomX Therapeutics, Inc. stock price is 3.95 USD today.
-
How to buy CytomX Therapeutics, Inc. stock online?You can buy CytomX Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-17 | 3.78 | 3.55 | 3.93 | 3.51 |
| Nov-18 | 3.44 | 3.66 | 3.69 | 3.42 |
| Nov-19 | 3.64 | 3.63 | 3.73 | 3.60 |
| Nov-20 | 3.69 | 3.77 | 3.94 | 3.69 |
| Nov-21 | 3.76 | 3.88 | 3.94 | 3.73 |
| Nov-24 | 3.89 | 3.97 | 4.25 | 3.89 |
| Nov-25 | 3.95 | 4.15 | 4.16 | 3.93 |
| Nov-26 | 4.20 | 4.22 | 4.25 | 4.07 |
| Nov-28 | 4.22 | 4.28 | 4.33 | 4.18 |
| Dec-1 | 4.19 | 4.29 | 4.31 | 4.05 |
| Dec-2 | 4.24 | 3.81 | 4.28 | 3.76 |
| Dec-3 | 3.81 | 4.00 | 4.02 | 3.66 |
| Dec-4 | 3.96 | 4.08 | 4.20 | 3.94 |
| Dec-5 | 4.08 | 3.95 | 4.09 | 3.92 |
CytomX Therapeutics, Inc. Earnings
Data Unavailable
CytomX Therapeutics, Inc. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.08 per share, and a decrease next year of $0.34 per share.
* CytomX Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.